<DOC>
	<DOC>NCT01025700</DOC>
	<brief_summary>Safety of Nabilone in reducing marijuana craving</brief_summary>
	<brief_title>Nabilone &amp; Marijuana Addiction</brief_title>
	<detailed_description>Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Nabilone</mesh_term>
	<criteria>19 years or older History of marijuana use</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>Marijuana</keyword>
	<keyword>Reduction</keyword>
	<keyword>Craving</keyword>
</DOC>